Markets

SPY755.72▼ -1.77%QQQ690.49▼ -3.47%DIA517.13▼ -1.07%GLD355.78▼ -3.47%TLT81.84▲ +0.43%BABA98.04▼ -1.51%NIO3.21▼ -3.31%PDD78.61▼ -0.85%Realtime derived data

$REGN

Independent coverage

927.89▲ +13.33%realtime derived

Independent research

Latest Research

Latest · 2026-10-31

Independent Researchsingle-name-earnings Earnings Results Data Desk2026-10-31

Regeneron Pharmaceuticals quarterly revenue jumps 36.3% to $5.12 billion

Regeneron Pharmaceuticals' revenue growth is speeding up. Results for the quarter ended September 30, 2026, from the earnings release filed with the SEC on Oct 30, 2026.

$REGN Octans Research

Coverage Timeline

2026-10-31

2026-10-31Regeneron Pharmaceuticals quarterly revenue jumps 36.3% to $5.12 billion

Regeneron Pharmaceuticals quarterly revenue jumps 36.3% to $5.12 billion→

Regeneron Pharmaceuticals quarterly revenue jumps 36.3% to $5.12 billion